Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Denosumab Counteracts Metabolic Bone Disease in Chronic Intestinal Failure Patients: A Randomized, Controlled Clinical Trial

NCT02853539 is registered in ClinicalTrials.gov with Stanley Dudrick's Memorial Hospital as lead sponsor.

NCT NCT02853539
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02853539 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Denosumab Counteracts Metabolic Bone Disease in Chronic Intestinal Failure Patients: A Randomized, Controlled Clinical Trial
Lead sponsor
Stanley Dudrick's Memorial Hospital
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2011
Completion date
July 31, 2016
Enrollment
32 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metabolic bone disease